NCT06299930View on ClinicalTrials.gov

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

CompletedOBSERVATIONAL
Enrollment

10,328

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

August 16, 2023

Study Completion Date

September 12, 2023

Conditions
Breast Cancer
Interventions
PROCEDURE

Neoadjuvant chemotherapy

Patients received neoadjuvant chemotherapy (either taxane-or anthracycline-based, or any cytotoxic chemotherapy) , followed by surgery and radiotherapy

PROCEDURE

Adjuvant chemotherapy

Patients received adjuvant chemotherapy (either taxane-or anthracycline-based, or any cytotoxic chemotherapy) after surgery, followed by radiotherapy

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER